zuihouyizhan918@gmail.com

Gastric (stomach) cancer remains a significant health challenge worldwide. While advancements in chemotherapy and immunotherapy have improved outcomes, researchers are increasingly looking toward $beta$-Glucan—a natural biological response modifier—as a potent ally to enhance treatment efficacy and patient survival. What is…

Prostate cancer is the most common cancer among men in the United States, second only to skin cancer. As medical science advances, the focus is shifting toward comprehensive care that not only targets the tumor but also strengthens the patient’s…

Facing a breast cancer diagnosis is one of life’s most challenging chapters. While standard treatments like chemotherapy and endocrine therapy are the “gold standards” for care, the search for supportive therapies to enhance well-being and treatment efficacy is more active…

Colorectal cancer (CRC) remains a significant health challenge in the United States, currently ranking as the second leading cause of cancer-related deaths among women and fourth overall. While surgery and chemotherapy are the standard “gold rules” for treatment, the medical…

The Clinical Challenge Hepatocellular Carcinoma (HCC) remains one of the most challenging malignancies due to its high rate of recurrence and the rapid development of resistance to multi-kinase inhibitors like Sorafenib. In the U.S. oncology landscape, the search for non-toxic…

Introduction In the evolving landscape of Non-Small Cell Lung Cancer (NSCLC) treatment, the focus has shifted from merely attacking the tumor to optimizing the host’s immune microenvironment. While targeted therapies like Sunitinib and Immune Checkpoint Inhibitors (ICIs) have revolutionized outcomes,…